Mode
Text Size
Log in / Sign up
Phase 4 Completed N=50 Randomized Triple-blind Treatment

The Effect of Adding Sufentanyl to Bupivacaine in Transversus Abdominis Plane Block to Reduce the Narcotic Dosage and Pain After Cesarean Delivery

Source: ClinicalTrials.gov NCT01516268 ↗
Enrolled (actual)
50
Serious AEs
8.0%
Results posted
Mar 2013
Primary outcomePrimary: Narcotic Dosage

Summary

Adding sufentanyl to bupivacain in Transversus Abdominis Plane (TAP) block under ultrasound guide can reduce narcotic dosage, side effects and pain after cesarean delivery.

Outcome Measures

OutcomeResultp-value
PRIMARY
Narcotic Dosage
37.2; 52.8
SECONDARY
Pain

Eligibility Criteria

Inclusion Criteria

  • female 18 to 40 Years
  • class ASA 1 and 2
  • candidates for elective cesarean section

Exclusion Criteria

  • renal failure
  • liver failure
  • cardiac disorder
  • coagulopathy
  • hepatomegaly
  • splenomegaly
  • drug sensitivity and abuse
  • morbid obesity
  • smoking
  • history of post operative nausea and vomiting
  • motion sickness
  • local hypoesthesia
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01516268). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search